Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects Of ATH-1105 In Models Of ALS At Motor Neurone Disease Association’S 35Th International Symposium On ALS/MND
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects Of ATH-1105 In Models Of ALS At Motor Neurone Disease Association’S 35Th International Symposium On ALS/MND . (MENAFN - GlobeNewsWire - Nasdaq) BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) --  Athira Pharma, Inc.  (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108965816/Athira-Pharma-Presents-Preclinical-Data-Highlighting-Neuroprotective-Effects-Of-ATH-1105-In-Models-Of-ALS-At-Motor-Neurone-Disease-AssociationS-35Th-International-Symposium-On-ALSMND
2024-12-06
rss
(MENAFN - GlobeNewsWire - Nasdaq) BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) --  Athira Pharma, Inc.  (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small ...
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects Of ATH-1105 In Models Of ALS At Motor Neurone Disease Association’S 35Th International Symposium On ALS/MND